2025-07-10 - Analysis Report
Okay, here's a comprehensive analysis of Teladoc Health Inc. (TDOC) based on the provided data.

**Report on Teladoc Health Inc. (TDOC)**

**0. Executive Summary**

Teladoc Health Inc. (TDOC) is a telehealth company offering virtual healthcare services.  TDOC has significantly underperformed the S&P 500. Recent technical indicators show some positive short-term momentum, but fundamental concerns persist, particularly regarding profitability and long-term expected returns. Recent news highlights volatility. A high-risk investment requiring careful monitoring.

**1. Performance vs. S&P 500 (VOO)**

*   **Ticker:** TDOC
*   **Company:** Teladoc Health Inc.
*   **Description:** Teladoc Health Inc. delivers virtual healthcare services.
*   **TDOC Cumulative Return:** -60.47%
*   **VOO Cumulative Return:** 95.99%
*   **Absolute Divergence:** -160.3
*   **Relative Divergence:** 0.0

**Analysis:** TDOC has significantly underperformed the S&P 500.  The large negative divergence (-160.3) and a relative divergence of 0.0 indicates that TDOC is performing at the low end of its historical range relative to the S&P 500.

**Alpha, Beta Analysis:**

| Year       | CAGR     | MDD    | Alpha    | Beta   | Cap(B) |
|------------|----------|--------|----------|--------|--------|
| 2015-2017  | 76.0%    | 60.6%  | 50.0%    | -0.0   | 6.1    |
| 2016-2018  | 128.0%   | 59.3%  | 110.0%   | -0.0   | 8.7    |
| 2017-2019  | 176.0%   | 59.3%  | 147.0%   | 0.4    | 14.7   |
| 2018-2020  | 237.0%   | 64.0%  | 217.0%   | 0.1    | 35.1   |
| 2019-2021  | -83.0%   | 64.0%  | -132.0%  | 0.1    | 16.1   |
| 2020-2022  | -295.0%  | 81.3%  | -297.0%  | 0.0    | 4.2    |
| 2021-2023  | -488.0%  | 81.3%  | -506.0%  | -0.6   | 3.8    |
| 2022-2024  | -111.0%  | 81.3%  | -137.0%  | -0.8   | 1.6    |
| 2023-2025  | -31.0%   | 72.9%  | -78.0%   | -0.8   | 1.6    |

**Analysis:** The Alpha and Beta analysis reveals several key trends:

*   **Declining Performance:**  CAGR and Alpha have significantly deteriorated over the more recent periods (2019-2025).  The negative CAGR values indicate substantial losses.
*   **High Volatility:** MDD (Maximum Drawdown) consistently remains high, indicating significant risk and price volatility.
*   **Beta Concerns:** The Beta values are fluctuating between negative and positive, indicating its volatility and sometimes contradicting correlation to the market.
*   **Market Cap Decline:**  Market capitalization (Cap) has declined significantly, implying a decrease in investor confidence and overall valuation of the company.

**2. Recent Price Action**

*   **Current Price:** 8.88
*   **Last Market Data:** {'price': 8.8793, 'previousClose': 8.51, 'change': 4.34}
*   **5-Day Moving Average:** 8.434
*   **20-Day Moving Average:** 7.753
*   **60-Day Moving Average:** 7.3153

**Analysis:**

*   The current price shows a 4.34% increase compared to the previous close, which is substantial and indicates a strong positive movement in the short term.
*   The price is above all three moving averages (5-day, 20-day, and 60-day), suggesting a short-term upward trend. The 5-day moving average is above the 20-day moving average, which is above the 60-day moving average. This confirms the upward trend.

**3. Technical Indicators and Expected Return**

*   **Market Risk Indicator (MRI):** 0.3373 (Low Risk)
*   **RSI:** 71.33 (Overbought)
*   **PPO:** 1.1833
*   **Hybrid Signal:** cash_0%_Buy 80% of cash (1 shares - Caution - MRI:0.34) (Cash Ratio: 0% on 2025-07-07)
*   **20-Day Relative Divergence Change:** -0.2 (Negative - Short-term Decline)
*   **Expected Return:** -9506.2%

**Analysis:**

*   **MRI:** The MRI indicates "Low Risk" in the market which means that it’s not so high but it may have risk in the future.
*   **RSI:**  The RSI value suggests that the stock may be overbought in the short term. This could signal a potential pullback.
*   **PPO:** Positive PPO value suggests an upward trend.
*   **Hybrid Signal:** The "Buy" signal with 80% of cash, alongside the "Caution" suggests a cautious approach despite the buying opportunity.
*   **20-Day Relative Divergence Change:** The negative change indicates a recent short-term decline, contrasting with the overall positive price action.
*   **Expected Return:** The extremely negative expected return (-9506.2%) indicates very high risk and suggests that long-term investment in TDOC may significantly underperform the S&P 500.
*   **Recent Price Change:** The significant price change of 4.34% suggests a recent catalyst or news event is influencing the stock. This warrants further investigation.

**4. Recent News & Significant Events**

*   **[2025-07-08]:** Major business developments, regulatory changes, or market events.
*   **[2025-07-07]:** Analyst discussions regarding performance, industry trends, and global economic factors.
*   **[2025-07-09]:** Notable stock volatility influenced by news, earnings reports, or executive actions.
*   **[2025-07-10]:** Market experts highlight risks and opportunities, advising monitoring of news and announcements.

**Analysis:** The news items suggest the company is undergoing significant changes and experiencing volatility. The analysts' discussions and expert opinions further emphasize the uncertainty and potential risks associated with TDOC.

**5. Recent Earnings Analysis**

| 날짜       | EPS   | 매출     |
|------------|-------|----------|
| 2025-05-01 | -0.53 | 0.63 B$  |
| 2024-10-31 | -0.19 | 0.64 B$  |
| 2024-08-01 | -4.92 | 0.64 B$  |
| 2024-04-26 | -0.49 | 0.65 B$  |
| 2025-05-01 | -0.49 | 0.65 B$ |

**Analysis:**

*   **Negative EPS:** EPS values are consistently negative, indicating losses for the company.
*   **Revenue:** Revenue is relatively stable around $0.63-0.65 billion.
*The most recent EPS is -0.49$, indicating that the company is generating a loss for each outstanding share.

**6. Financial Information**

**Revenue and Profitability:**

| Quarter      | Revenue | Profit Margin |
|--------------|---------|---------------|
| 2025-03-31   | $0.63B  | 68.73%        |
| 2024-12-31   | $0.64B  | 70.50%        |
| 2024-09-30   | $0.64B  | 71.94%        |
| 2024-06-30   | $0.64B  | 70.73%        |
| 2024-03-31   | $0.65B  | 69.89%        |

**Capital and Profitability:**

| Quarter      | Equity   | ROE       |
|--------------|----------|-----------|
| 2025-03-31   | $1.43B   | -6.52%    |
| 2024-12-31   | $1.49B   | -3.25%    |
| 2024-09-30   | $1.51B   | -2.21%    |
| 2024-06-30   | $1.50B   | -55.77%   |
| 2024-03-31   | $2.29B   | -3.58%    |

**Analysis:**

*   **Revenue:** Revenue has been stable around $0.63-0.65B.
*   **Profit Margin:** Profit margins are relatively high, indicating efficient cost management.
*   **Equity:** Equity has decreased over the past year, suggesting either losses or distribution of capital.
*   **ROE:** Return on Equity is consistently negative, confirming the company is not generating profits relative to its equity base.

**7. Overall Analysis and Conclusion**

Based on the provided data, Teladoc Health Inc. (TDOC) presents a high-risk investment profile:

*   **Poor Historical Performance:**  Significant underperformance compared to the S&P 500, as evidenced by the large negative divergence and relative divergence of 0.
*   **Declining Financial Health:** Negative EPS, negative ROE, and decreasing equity indicate serious profitability issues.
*   **High Volatility:**  High MDD and recent news suggest considerable volatility.
*   **Conflicting Signals:**  While recent price action and some technical indicators show short-term positive momentum (price above moving averages, recent price increase), the extremely negative expected return and the "Caution" hybrid signal emphasize the underlying fundamental risks.
* **Valuation:** TDOC's Equity has decreased over the past year, from 2.29B$ to 1.43B$ with market capitalization of 1.6B$.
*   **News and Events:** Recent news points to volatility and significant developments that investors should closely monitor.

**Recommendation:**  While the recent upward price movement might be tempting, the fundamental weaknesses and negative long-term outlook suggest that TDOC is a highly speculative investment. The company requires careful monitoring.
